Skip to content
Abierto

Special notice

VISN IDIQ LENALIDOMIDE Sole Source Justification

36C24226F0064

Department of Veterans Affairs, 242-Network Contract Office 02. Pharmaceutical Preparation Manufacturing.

Response deadline

May 19, 2026 at 4:00 PM EDT

Closed 122 days ago. Posted May 5, 2026. Scheduled to archive August 26, 2026.

Description

As published on SAM.gov.

This is a notice of intent to award a Sole-Source only contract and is not a request for quotes.

Name of Proposed Contractor Exelan Pharmaceuticals Street Address: 370 W. Camino Gardens, Suite 204 City, State, Zip: Boca Raton, FL 334432 The objective of this action is the procurement for: The purpose of this contract is to establish a reliable and continuous supply of Lenalidomide, an immunomodulatory drug used primarily to treat multiple myeloma, anemia in myelodysplastic syndromes (MDS) in adults, and certain types of lymphoma.

Lenalidomide works by enhancing the immune system s ability to fight cancer cells. It inhibits the growth of new blood vessels in tumors and alters the immune response to target and destroy malignant cells. It comes with serious risks that require careful management and monitoring.

Contractor shall provide all materials, labor, and equipment necessary to supply Lenalidomide in accordance with all applicable federal regulations, Good Manufacturing Practices (cGMP) and the Food and Drug Administration (FDA) requirements. This is an emergent need to ensure continuous supply, to meet regulatory obligations (Risk Evaluation and Mitigation Strategy REMS) program, and to support patient access.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 5, 2026

    Special notice

    Due May 19, 2026 at 4:00 PM EDT. SAM.gov, notice 897f7dd2fe914f36b93c8a5841637e8e

Points of contact